ArticleBMC palliative care2026
Unequal goodbyes: disparities in end-of-life care before and after the outbreak of the COVID-19 pandemic across 28 countries.
Article in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic significantly disrupted health systems, impacting how individuals received end-of-life (EOL) care and amplifying pre-existing differences in healthcare use across sociodemographic groups. While research has examined the burden placed on healthcare professionals, less attention has been paid to the experience of care recipients in their final year of life, particularly across different socioeconomic groups. This study explores the sociodemographic factors associated with the care that people received in the last year of life, comparing periods before and after the outbreak of the pandemic across Europe.
methodsThe analysis uses data from 5,029 deceased individuals aged over 50, who died between 2018 and 2022. Data include 28 European countries and are drawn from waves 7-9 of the Survey of Health, Ageing and Retirement in Europe. Information was collected via proxy interviews post-mortem and includes details on health, care received in the final year of life, and sociodemographic characteristics. The main outcomes were six binary variables indicating the utilization of care in the hospital, hospice, nursing home, home care, care from a general practitioner, and from a specialist physician. Using six binary probit regression models, we estimated the average marginal effects of dying after the onset of the pandemic (March 2020), with interaction terms for cause of death, education level, and financial difficulty.
resultsEOL care use declined following the pandemic's onset, with particularly steep reductions in home-based care and specialist services. These changes varied across population groups. Dying from cardiovascular or infectious causes was associated with significant declines in hospital, home, and specialist care use. Socioeconomic disparities widened: low education levels were associated with decreases across all care types except nursing homes, while reporting financial hardships was associated with marked reductions particularly in home care and specialist care use. Individuals with higher education or financial security saw smaller or no significant changes in care use.
conclusionsPatterns observed during the pandemic suggest that pre-existing differences in EOL care across Europe might have widened, and lower education and financial resources were associated with lower EOL care use. These results underscore the urgent need for policies that build resilient, equitable EOL care systems capable of protecting disadvantaged populations in times of crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.